Abatacept phase 2 shows benefits for Psoriatic Arthritis.
Links shared publicly online about this topic.
New research suggests that the T-cell inhibitor abatacept (Orencia, Bristol-Myers Squibb) can be beneficial in treating the joint manifestations of psoriatic arthritis, with lesser effects on the disease--™s skin component, MedPage Today reports. ... View full resource at psoriasisclub.forumotion.org
Tags: Dermatology, Psoriasis, Arthritis, Rheumatoid Arthritis Medication, Spondyloarthropathy, Psoriatic Arthritis, Orencia, Rheumatology
Most Recently Shared on April 20, 2011 at 1:53 pm By: